Current Issue
Volume:
Number:
Index: 2010
Clinical Focus:
Call For Papers
January 2010
Clinical Focus: Emergency Medicine
Emergency Medicine:
  • Vascular emergencies
  • Defying diagnosis: nonspecific abdominal pain
  • New devices and products in emergency care
  • Health economics: emergency department overcrowding
  • Obese patients in the emergency department: critical care considerations
  • Imaging chest pain in the emergency department
  • Pediatric airway management
  • Procedural sedation considerations
  • The crashing patient: pre- or post-cardiac arrest
  • Misdiagnosis of chest pain
  • New cardiac drugs
  • Minimizing door-to-balloon times
  • Management of pulmonary failure in the emergency department
  • Approach to the unknown rash
  • New therapies to improve survival in septic patients
  • Detecting DVT: venous access in the emergency department
  • Bedside echocardiography
  • Head CT findings
  • C-spine imaging considerations
  • Facial anesthesia
  • Removal of foreign bodies
  • ENT emergencies
  • Reversing medications that cause bleeding
  • Infections in immunocompromised adults
  • HIV and the emergency department patient
  • Care of combative, altered, and agitated patients
  • Altered mental status in the elderly: neurological considerations
  • Combat casualty care: civilian applications
  • Acute respiratory failure: noninvasive ventilatory support in the emergency department
  • Community-acquired pneumonia
  • Pulmonary embolism monitoring and avoidance
  • Drug interactions: combinations that can kill
  • Poison management
  • Trauma in special populations
  • Protecting the kidneys: medication and contrast considerations
  • Hemostasis - stopping bleeding
  • Controversies in acute stroke care
Cardiovascular:
  • Implications of recent clinical CV trials for daily practice
  • Stroke
  • Antiplatelet therapy
  • Clinical trials
  • Hypertension treatment options in different patient populations
  • Statin therapy
  • Angiotensin receptor blockers
  • Angiotensin-converting enzyme inhibitors
  • Calcium channel blockers
  • Combination therapies
  • Aortic atherosclerosis, hypercoagulability, and stroke
  • Assisted circulation in heart failure
  • Atherosclerotic process in patients with hypercholesterolemia
  • Primary prevention of cardiovascular disease
  • Treatment options for elderly patients with congestive heart failure
  • Ectopic fat and cardiovascular disease
  • New-onset heart failure: worsening epidemic
  • Sleep-disordered breathing as a cardiovascular risk factor
  • Patient nonadherence and effect on clinical practice
  • Successful lifestyle changes for cardiovascular risk reduction
  • Imaging of vulnerable plaque and atherosclerosis
  • Molecular imaging of vascular disease
  • Genetics of PAD
  • Managing asymptomatic aortic stenosis
  • Limiting myocardial infarct size
  • Controversies in acute stroke care
  • Surgical therapies for heart failure
  • Improving outcomes after cardiac arrest
  • Heart failure with preserved systolic function
  • Current choices in PCI pharmacology
  • Diagnosis and treatment of thoracic aortic disease
  • Drugs in ACS
  • Cardiovascular complications of recreational drugs
  • Management of ischemic heart disease in high-risk populations
  • Improving survival from cardiac arrest
  • Imaging of cardiac risk in patients with diabetes
Submission deadline: December 01
Fast-Track deadline: December 15
About
Fast-Track peer review is available for those papers requiring immediate review (for an additional fee). Complete peer review is finalized in 1-2 weeks and comments are provided to the author within 72 hours of their receipt by the editorial office. Authors are asked to submit a revised manuscript within 10-12 days. Accepted manuscripts are processed within 2-3 weeks, published online within 3 business days of final author approval, and in print in the next available issue.
Submissions
*NEW* Submit your FAST-TRACK manuscript online today. It's fast, it's easy! Just follow the detailed instructions, fill in all the required fields, and upload your manuscript.
Get started NOW!
Contacts
Libraries:
sitelicenses@postgradmed.com

Reprints:
reprints@postgradmed.com

Subscriptions:
subscriptions@postgradmed.com

Supplements:
supplements@postgradmed.com

Document Delivery Services 1946-2010:
documentdelivery@postgradmed.com

Editorial:
editor-in-chief@postgradmed.com editorial@postgradmed.com

Website:
support@postgradmed.com

Managing Director:
John Elduff
Phone: 610-889-3733
Fax: 1-866-297-3168
j.elduff@postgradmed.com

General Information
Phone: 610-889-3733
Fax: 1-866-297-3168
1235 Westlakes Drive
Suite 220
Berwyn, PA 19312
January 4, 2010
Index - Table of Content - Article
Most Viewed
  1. The Bioidentical Hormone Debate:
    Are Bioidentical Hormones (Estradiol, Estriol, and Progesterone) Safer or More Efficacious than Commonly Used Synthetic Versions in Hormone Replacement Therapy?
  2. Nonalcoholic Fatty Liver Disease:
    Hepatic Manifestation of Obesity and the Metabolic Syndrome
  3. Prevention, Screening, and Management of Osteoporosis:
    An Overview of the Current Strategies
Weekly Poll
In 1973, the American Heart Association became the first voluntary public agency to campaign against cigarette smoking.


doi:
: Volume : No.
Copyright 2010 All rights reserved. Cover and contents may not be reproduced in whole or in part without prior written permission. Postgraduate Medicine is a registered trademark of JTE Multimedia, LLC. Sending and distribution of any document from this site is strictly prohibited either for free and or a service fee, and will be sited as a violation of copyright under the laws of THE UNITED STATES OF AMERICA





Disclaimer
In an effort to provide information that is scientifically accurate and consistent with accepted standards of medical practice, the editors and publisher of Postgraduate Medicine routinely consult sources believed to be reliable. However, readers are encouraged to confirm this information with other sources. For example and in particular, physicians are advised to consult the prescribing information in the manufacturer's package insert before prescribing any drug mentioned.


Back to the table of contents for the issue